We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNV
1276
DELISTED
Synovus
SNV
| $637K | ﹤0.01% |
21,049
-5,048
| -19% | -$148K |
|
|
SRCL
1277
DELISTED
Stericycle Inc
SRCL
| $634K | ﹤0.01% |
13,661
+407
| +3% | +$17.8K |
|
1278
A10 Networks
ATEN
$1.93B
| $634K | ﹤0.01% |
43,462
+43,350
| +38,705% | +$627K |
|
1279
Qiagen
QGEN
$8.86B
| $632K | ﹤0.01% |
13,231
+2,747
| +26% | +$132K |
|
|
FYBR
1280
DELISTED
Frontier Communications
FYBR
| $630K | ﹤0.01% |
33,803
+1,198
| +4% | +$22.5K |
|
1281
General Dynamics
GD
$97.4B
| $629K | ﹤0.01% |
2,922
-576
| -16% | -$124K |
|
1282
Peoples Bancorp
PEBO
$1.42B
| $628K | ﹤0.01% |
23,641
+4,165
| +21% | +$109K |
|
|
SLRN
1283
DELISTED
ACELYRIN
SLRN
| $627K | ﹤0.01% |
+30,000
| New | +$614K |
|
1284
Pinnacle Financial Partners Inc
PNFP
$14.5B
| $626K | ﹤0.01% |
11,053
-333
| -3% | -$17.5K |
|
|
PCH
1285
DELISTED
PotlatchDeltic
PCH
| $626K | ﹤0.01% |
11,845
+276
| +2% | +$13.3K |
|
1286
Post Holdings
POST
$3.56B
| $625K | ﹤0.01% |
7,213
-264
| -4% | -$23.2K |
|
1287
Bank OZK
OZK
$5.23B
| $624K | ﹤0.01% |
15,541
-1,206
| -7% | -$43.3K |
|
1288
MGM Resorts International
MGM
$9.66B
| $622K | ﹤0.01% |
14,171
+4,233
| +43% | +$181K |
|
1289
Shake Shack
SHAK
$2.29B
| $622K | ﹤0.01% |
+8,005
| New | +$514K |
|
1290
Coty
COTY
$2.32B
| $621K | ﹤0.01% |
50,563
-2,443
| -5% | -$28.8K |
|
1291
Moderna
MRNA
$58.1B
| $621K | ﹤0.01% |
5,110
-54,342
| -91% | -$7.25M |
|
|
MPT
1292
Medical Properties Trust
MPT
$2.02B
| $618K | ﹤0.01% |
66,731
-1,270
| -2% | -$10.7K |
|
|
FISV
1293
Fiserv Inc
FISV
$26.3B
| $616K | ﹤0.01% |
4,885
+797
| +19% | +$93.8K |
|
1294
Euronet Worldwide
EEFT
$2.58B
| $615K | ﹤0.01% |
5,238
-1,532
| -23% | -$171K |
|
1295
Fluor
FLR
$7.09B
| $614K | ﹤0.01% |
20,758
-121
| -0.6% | -$3.47K |
|
1296
Perrigo
PRGO
$1.88B
| $614K | ﹤0.01% |
18,097
-1,639
| -8% | -$56.9K |
|
1297
Photronics
PLAB
$1.64B
| $611K | ﹤0.01% |
23,705
+17,981
| +314% | +$333K |
|
1298
Akamai
AKAM
$15B
| $610K | ﹤0.01% |
6,789
-1,244
| -15% | -$107K |
|
1299
Expeditors International
EXPD
$24.6B
| $606K | ﹤0.01% |
5,003
+1,822
| +57% | +$207K |
|
1300
Grand Canyon Education
LOPE
$4.01B
| $605K | ﹤0.01% |
5,865
-2,139
| -27% | -$235K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.